Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 2, 2019
Randomized, double-blind, placebo-controlled study of F17464, a preferential D<sub>3</sub> antagonist, in the treatment of acute exacerbation of schizophreniaIstvan Bitter, Jeffrey A Lieberman, Florence Gaudoux, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 3, 2004
Glyceraldehyde-3-phosphate dehydrogenase is a GABAA receptor kinase linking glycolysis to neuronal inhibitionJacques J Laschet, Frédéric Minier, Irène Kurcewicz, et al.The International Journal of Neuropsychopharmacology|June 15, 2007
Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotypeBruno P Guiard, Denis J P David, Thierry Deltheil, et al.Psychopharmacology|November 28, 2019
Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [<sup>11</sup>C]-(+)-PHNOMark Slifstein, Anissa Abi-Dargham, Ragy R Girgis, et al.Parkinsonism & Related Disorders|May 12, 2005
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptorsC Guigoni, I Aubert, Q Li, et al.Nature Communications|November 7, 2024
FLT3 signaling inhibition abrogates opioid tolerance and hyperalgesia while preserving analgesiaAntoine Jouvenel, Adrien Tassou, Maxime Thouaye, et al.Nature Communications|March 14, 2018
Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in miceCyril Rivat, Chamroeun Sar, Ilana Mechaly, et al.Pageof 5